trevicta 175 mg prefilled syringe

Trevicta prefilled injection is a long-acting antipsychotic medication developed for the maintenance treatment of chronic psychiatric disorders. Its extended-release formulation provides sustained therapeutic effects, helping patients maintain long-term psychiatric stability.

The medication helps restore the natural chemical balance in the brain, reducing the severity of psychotic symptoms and lowering the risk of relapse. This allows patients to achieve better daily functioning and an improved quality of life.

Drug Ingredients

• Paliperidone.

Available Strengths

• Prefilled injection containing 175 mg.

• Prefilled injection containing 263 mg.

• Prefilled injection containing 350 mg.

• Prefilled injection containing 525 mg.

Indications of Trevicta

• Maintenance treatment of schizophrenia in clinically stable adult patients.

• Control of psychotic symptoms and prevention of disease relapse.

• Improvement of mood and behavioral disturbances associated with schizophrenia.

• Enhancement of clear thinking and reduction of auditory or visual hallucinations.

Dosage

The extended-release injection is administered once every three months according to the treatment schedule prescribed by the physician. Patients are generally switched to this formulation only after they have been stabilized on monthly Paliperidone injections and have demonstrated good tolerability.

It is important to receive each injection on schedule and not delay or administer it earlier than planned without consulting the physician to maintain consistent therapeutic effectiveness.

Side Effects

• Weight gain and changes in appetite.

• Mild drowsiness, fatigue, or dizziness, especially at the beginning of treatment.

• Mild pain or swelling at the intramuscular injection site.

• Mild movement disorders or temporary muscle stiffness in some patients.

Contraindications

• Do not use this medication if you have a known hypersensitivity to Paliperidone, Risperidone, or any of the other ingredients.

• It should also not be used in patients with severe cardiac rhythm disorders or elderly patients with dementia-related psychosis because of the increased risk of serious cardiovascular events and stroke.

Alternatives

• Invega.

• Risperdal Consta.

• Zypadhera.

• Abilify Maintena.

Use During Pregnancy and Breastfeeding

This medication should be used with extreme caution during pregnancy and breastfeeding. It is not recommended during pregnancy unless the physician determines that the expected benefits outweigh the potential risks to the fetus, and it should only be used under close medical supervision.

Consult your physician before using this medication while breastfeeding, as the active ingredient may pass into breast milk. Your physician may recommend temporarily discontinuing breastfeeding or choosing a more appropriate alternative treatment based on the condition of both the mother and the infant.

Storage Conditions

• Store in a dry place at a temperature below 30°C. Do not freeze.

• Keep the medication in its original package to protect it from moisture and direct light.

• Store in a secure place out of the sight and reach of children.